Literature DB >> 17613496

The validity of serum levels as a surrogate measure of systemic exposure to metal ions in hip replacement.

J Daniel1, H Ziaee, P B Pynsent, D J W McMinn.   

Abstract

Metal ions generated from joint replacements are a cause for concern. There is no consensus on the best surrogate measure of metal ion exposure. This study investigates whether serum and whole blood concentrations can be used interchangeably to report results of cobalt and chromium ion concentrations. Concentrations of serum and whole blood were analysed in 262 concurrent specimens using high resolution inductively-coupled plasma mass-spectrometry. The agreement was assessed with normalised scatterplots, mean difference and the Bland and Altman limits of agreement. The wide variability seen in the normalised scatterplots, in the Bland and Altman plots and the statistically significant mean differences between serum and whole blood concentrations suggest that they cannot be used interchangeably. A bias was demonstrated for both ions in the Bland-Altman plots. Regression analysis provided a possible conversion factor of 0.71 for cobalt and 0.48 for chromium. However, even when the correction factors were applied, the limits of agreement were greater than +/-67% for cobalt and greater than +/-85% for chromium, suggesting that serum and whole blood cannot be used interconvertibly. This suggests that serum metal concentrations are not useful as a surrogate measure of systemic metal ion exposure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613496     DOI: 10.1302/0301-620X.89B6.18141

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  21 in total

1.  Surgical variables influence metal ion levels after hip resurfacing.

Authors:  Nicholas M Desy; Stephane G Bergeron; Alain Petit; Olga L Huk; John Antoniou
Journal:  Clin Orthop Relat Res       Date:  2011-06       Impact factor: 4.176

2.  'Pseudotumour' invading the proximal femur with normal metal ions following metal on metal hip resurfacing.

Authors:  Harry Krishnan; Kapil Sugand; Ibrahim Ali; Jay Smith
Journal:  BMJ Case Rep       Date:  2015-02-10

3.  Differences in concentration of metal debris in blood, serum, and plasma samples of patients with metal-on-metal hip resurfacing arthroplasty.

Authors:  M Khan; J H Kuiper; Christine Sieniawska; J B Richardson
Journal:  J Orthop       Date:  2015-12-09

4.  What are the risks accompanying the reduced wear benefit of low-clearance hip resurfacing?

Authors:  Joseph Daniel; Hena Ziaee; Amir Kamali; Chandra Pradhan; Derek McMinn
Journal:  Clin Orthop Relat Res       Date:  2012-07-24       Impact factor: 4.176

5.  Femoral head size does not affect ion values in metal-on-metal total hips.

Authors:  Mitchell Bernstein; Alan Walsh; Alain Petit; David J Zukor; Olga L Huk; John Antoniou
Journal:  Clin Orthop Relat Res       Date:  2011-06       Impact factor: 4.176

6.  Long-term follow-up and metal ion trend of patients with metal-on-metal total hip arthroplasty.

Authors:  Mitchell Bernstein; Nicholas M Desy; Alain Petit; David J Zukor; Olga L Huk; John Antoniou
Journal:  Int Orthop       Date:  2012-06-09       Impact factor: 3.075

7.  Metal-on-Metal Hip Joint Prostheses: a Retrospective Case Series Investigating the Association of Systemic Toxicity with Serum Cobalt and Chromium Concentrations.

Authors:  James H Ho; Jerrold B Leikin; Paul I Dargan; John R H Archer; David M Wood; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2017-09-12

8.  [In vitro analysis of the impact of metal ions on human lymphocyte cultures].

Authors:  S Hagmann; J Kirsch; J P Kretzer; B Moradi
Journal:  Orthopade       Date:  2013-08       Impact factor: 1.087

9.  Cobalt-induced cardiomyopathy - do circulating cobalt levels matter?

Authors:  Mark R J Jenkinson; R M Dominic Meek; Rothwell Tate; Sandy MacMillan; M Helen Grant; Susan Currie
Journal:  Bone Joint Res       Date:  2021-06       Impact factor: 5.853

10.  Metal ion levels and lymphocyte counts: ASR hip resurfacing prosthesis vs. standard THA: 2-year results from a randomized study.

Authors:  Jeannette Ø Penny; Jens-Erik Varmarken; Ole Ovesen; Christian Nielsen; Søren Overgaard
Journal:  Acta Orthop       Date:  2013-04       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.